Author: Lynne Taylor

Current prescribing of warfarin, the main anticoagulant used in the UK to prevent blood clots from forming in the heart, is only half what it should be, and prescribing the drug for all eligible patients with atrial fibrillation would save the NHS £124 million a year, with further savings to social care, according to new research.

The introduction of biosimilar versions of complex biologic drugs to treat illnesses such as cancer and rheumatoid arthritis could cut US spending on biologics by $44 billion over the next decade, says new research.

Professor Sir Michael Rawlins has been appointed as the new chair of the Medicines and Healthcare products Regulatory Agency.

The three treatment targets for diabetes – controlling blood pressure, blood sugar and cholesterol – are being met for just a third of patients in England, Public Health England has reported.

Sales of drugs to treat age-related macular degeneration in the G7 pharmaceutical markets are set to grow 6% a year, reaching nearly $9 billion in 2023, say new forecasts.